Immunotherapy Biomarkers

HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
Chu-Yu Jing, Yi-Peng Fu, Yong Yi, Mei-Xia Zhang, Su-Su Zheng, Jin-Long Huang, Wei Gan, Xin Xu, Jia-Jia Lin, Juan Zhang, Shuang-Jian Qiu, Bo-Heng Zhang

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 77; DOI: 10.1186/s40425-019-0554-8
Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells
Minjun C. Apodaca, Amy E. Wright, Angela M. Riggins, William P. Harris, Raymond S. Yeung, Lei Yu, Chihiro Morishima

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 230; DOI: 10.1186/s40425-019-0674-1
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Yiyin Zhang, Jin Xu, Jie Hua, Jiang Liu, Chen Liang, Qingcai Meng, Miaoyan Wei, Bo Zhang, Xianjun Yu, Si Shi

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 233; DOI: 10.1186/s40425-019-0703-0
Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
Biagio Ricciuti, Sasha Kravets, Suzanne E. Dahlberg, Renato Umeton, Adem Albayrak, Safiya J. Subegdjo, Bruce E. Johnson, Mizuki Nishino, Lynette M. Sholl, Mark M. Awad

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 87; DOI: 10.1186/s40425-019-0572-6
The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
Yaxiong Zhang, Lianpeng Chang, Yunpeng Yang, Wenfeng Fang, Yanfang Guan, Aiwei Wu, Shaodong Hong, Huaqiang Zhou, Gang Chen, Xi Chen, Shen Zhao, Qiufan Zheng, Hui Pan, Lanjun Zhang, Hao Long, Haoxian Yang, Xin Wang, Zhesheng Wen, Junye Wang, Hong Yang, Xuefeng Xia, Yuanyuan Zhao, Xue Hou, Yuxiang Ma, Ting Zhou, Zhonghan Zhang, Jianhua Zhan, Yan Huang, Hongyun Zhao, Ningning Zhou, Xin Yi, Li Zhang

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 98; DOI: 10.1186/s40425-019-0581-5
Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma
Swati Gupta, Leena McCann, Yvonne G. Y. Chan, Edwin W. Lai, Wei Wei, Pok Fai Wong, James W. Smithy, Jodi Weidler, Brian Rhees, Michael Bates, Harriet M. Kluger, David L. Rimm

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 254; DOI: 10.1186/s40425-019-0731-9
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
Hao-Xiang Wu, Yan-Xing Chen, Zi-Xian Wang, Qi Zhao, Ming-Ming He, Ying-Nan Wang, Feng Wang, Rui-Hua Xu

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 264; DOI: 10.1186/s40425-019-0737-3
A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity
Patrick Danaher, Sarah Warren, SuFey Ong, Nathan Elliott, Alessandra Cesano, Sean Ferree

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 15; DOI: 10.1186/s40425-018-0472-1
CD45RA⁺CCR7⁻ CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
Andre Kunert, Edwin A. Basak, Daan P. Hurkmans, Hayri E. Balcioglu, Yarne Klaver, Mandy van Brakel, Astrid A. M. Oostvogels, Cor H. J. Lamers, Sander Bins, Stijn L. W. Koolen, Astrid A. M. van der Veldt, Stefan Sleijfer, Ron H. J. Mathijssen, Joachim G. J. V. Aerts, Reno Debets

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 149; DOI: 10.1186/s40425-019-0608-y
The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients
Douglas Donnelly, Shirin Bajaj, Jaehong Yu, Miles Hsu, Arjun Balar, Anna Pavlick, Jeffrey Weber, Iman Osman, Judy Zhong

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 222; DOI: 10.1186/s40425-019-0699-5

Main menu

Immunotherapy Biomarkers

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy Biomarkers

Pages